Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada

April 16, 2019


BURLINGTON, Ontario – April 16, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates...

Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update

April 10, 2019


BURLINGTON, Ontario – April 10, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Mr. Ian Fodie has been appointed Chief Financial Officer effectively immediately. Mr. Fodie replaces Mr. Lino...

Rapid Dose Therapeutics and Thrive Cannabis Sign MOU to Provide Quickstrip™ Oral Thin Strips Under a White Label Manufacturing Agreement

March 13, 2019


BURLINGTON, Ontario – March 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Memorandum of Understanding (“MOU”) February 27, 2019...

Rapid Dose Therapeutics Corp. Grants Stock Options

March 11, 2019


Burlington, Ontario – March 11, 2019– Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) announces the grant of options to directors, officers, employees and consultants to purchase 4,526,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or...

Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT’s Case is Dismissed.

March 5, 2019


BURLINGTON, Ontario – March 5, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT...

Rapid Dose Therapeutics Corp. Announces Amalgamation with its Wholly-Owned Subsidiary, Rapid Dose Therapeutics Inc.

March 4, 2019


Burlington, Ontario — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce the completion of a vertical amalgamation (the “Amalgamation”) with its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., pursuant to section 177 of the Business Corporations Act (Ontario). The Amalgamation...

Rapid Dose Therapeutics Business Update

February 26, 2019


BURLINGTON, Ontario – February 26, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug delivery solutions, is pleased to provide a business update. RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral...

Rapid Dose Therapeutics Enters into Advisory Agreement with Spinnaker Capital Markets

February 14, 2019


BURLINGTON, Ontario – February 14, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) is pleased to announce that it has appointed Spinnaker Capital Markets Inc. (“Spinnaker”) as its capital markets and investor relations advisor. Spinnaker is a Toronto-based advisory firm which provides public companies...

Rapid Dose Therapeutics Announces Appointment of Dr. Gabriela Radulescu as Medical Director

January 23, 2019


BURLINGTON, Ontario – January 23, 2019 – Rapid Dose Therapeutics (“RDT”) (CSE: DOSE) is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT. Dr. Radulescu is a physician with 20 years of experience in the pharmaceutical industry. She brings to the...

Rapid Dose Therapeutics Announces Launch of its Innovative Quickstrip™ Product to the Nevada Cannabis Market Through Brand Partnership with Flower One

January 15, 2019


BURLINGTON, Ontario – January 15, 2019 – Rapid Dose Therapeutics Inc. (“RDT”) (CSE: DOSE) is pleased to announce its entered into a definitive agreement (the “Agreement”) on January 10, 2019, with Flower One Holdings Inc. (“Flower One”) (CSE: FONE) (OTCQB: FLOOF) pursuant to which Flower...

1 2 3